Archive
Every story, newest first.
Tuesday, November 3, 2026
Rates
The Bank of England has approved a link between HSBC and LSEG's digital securities depositories for DIGIT, the UK's first digitally native government bond, and the six lead banks have been given their specific roles for the pilot issuance expected by the first quarter of 2027.
Commodities
United States LNG exports reached their second highest monthly level on record in October, with shipments to Europe rising by 1 million tonnes to 6.89 million tonnes, according to LSEG data cited by Reuters.
Commodities
Copper fell 1.2 percent to 14,180 dollars a tonne and tin fell 2.2 percent to 48,550 dollars a tonne on Tuesday as a renewed selloff in Asian technology stocks weakened the demand outlook for data centre and circuit board metals.
Commodities
The world's biggest miners have lost 712 billion dollars in market value since the start of the Iran war, Canada's 2025 field crop production rose 11 percent to 109.3 million tonnes, and Dutch potato and onion harvests came in well below last year's records.
Commodities
China's soybean oil inventories surged to a record as elevated crushing rates boosted supply while edible oil consumption stayed sluggish, Bloomberg reported on Tuesday.
Commodities
Central banks bought a net 321 tonnes of gold in the third quarter of 2026, up 42 percent from a year earlier and the largest quarterly total since the end of 2024, the World Gold Council said on Tuesday.
Commodities
Orders for alternative fuelled vessels are running 57 percent ahead of last year, with 364 ships ordered so far in 2026 and LNG accounting for 230 of them, classification society DNV said.
Life Sciences
The FDA has placed a partial clinical hold on Bright Minds Biosciences' planned Phase 2 trial of BMB-101 in developmental and epileptic encephalopathies, citing toxicity in mice and insufficient data to support enrolling children.
Life Sciences
CinRx Pharma and Graviton BioScience have formed a jointly governed company, CinRock Pharma, to develop two ROCK2 inhibitor candidates for pulmonary arterial hypertension and heart failure with preserved ejection fraction.
Life Sciences
Brise Pharmaceuticals has disclosed the terms of its 2024 licence with AbbVie covering two preclinical migraine programmes, worth up to 757 million dollars in milestones plus royalties.